Showing results (141-150 of 152) with videos related to
Sort By:
Pageof 16
Nature Biotechnology|March 14, 2026
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumorsXiaotian Zhao, Weiqiang Jing, Ganyu Wang, et al.Cancer Research|August 13, 2024
YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate CancerHongtao Song, Tong Lu, Donghui Han, et al.Clinical Genitourinary Cancer|June 7, 2025
Erdafitinib versus Chemotherapy in Fibroblast Growth Factor Receptor-Altered Advanced or Metastatic Urothelial Cancer After Progression on Anti-programmed Death-(Ligand) 1 Therapy: An Exploratory Analysis of the Asian Subpopulation in the THOR Phase 3 StudyNobuaki Matsubara, Yohann Loriot, Earle F Burgess, et al.Cancer Medicine|April 6, 2023
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 studySujun Han, Zhigang Ji, Junhui Jiang, et al.World Journal of Urology|November 15, 2025
Prophylactic laxative use for postoperative constipation in urological cancer: a real-world cohort studyWasilijiang Wahafu, Feiya Yang, Tiejun Yang, et al.Molecular Cancer|April 29, 2024
Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistanceJianfeng Cui, Xiaochen Liu, Qinghong Shang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
Transrectal Ultrasound-Guided Prostate Biopsy With and Without PSMA PET-Targeted Prostate Biopsy for Prostate Cancer DiagnosisJianhua Jiao, Shuaijun Ma, Peng Wu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 1, 2024
Genetically Engineered Membrane-Coated Nanoparticles for Enhanced Prostate-Specific Membrane Antigen Targeting and Ferroptosis Treatment of Castration-Resistant Prostate CancerYu Li, Hongji Li, Keying Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2024
Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE TrialFred Saad, Egils Vjaters, Neal Shore, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 20, 2024
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective StudyLongbin Xiong, Xingli Shan, Huali Ma, et al.Pageof 16